Medifast, Inc.
Medifast, Inc. (MED) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
med · stock forecast · 12 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 12 Wall Street analysts in the past 3 months
Hold
12 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$12.00
Consensus
$12.00
-0.8% upside
Low
$12.00
Median: $12 · Last Close: $12.10
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $11.96 | ↓ 1.16% |
1-day model range: $11.86–$12.06. Peak: $12.06 (-1.16%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $6 | -50.0% |
| 2028 | $5 | -62.5% |
| 2029 | $4 | -67.2% |
| 2030 | $4 | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MED · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-02-19 | Stephens & Co. | Maintains | Equal Weight→Equal Weight |
| 2025-02-19 | DA Davidson | Maintains | Neutral→Neutral |
| 2024-11-05 | DA Davidson | Upgrade ↑ | Underperform→Neutral |
| 2024-07-22 | DA Davidson | Maintains | Underperform→Underperform |
| 2024-06-05 | DA Davidson | Downgrade ↓ | Neutral→Underperform |
| 2024-04-30 | DA Davidson | Maintains | Neutral→Neutral |
| 2024-02-21 | DA Davidson | Maintains | Neutral→Neutral |
| 2023-08-08 | DA Davidson | Maintains | Neutral→Neutral |
| 2023-07-31 | DA Davidson | Maintains | Neutral→Neutral |
| 2023-05-02 | DA Davidson | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Medifast, Inc. (MED) stock. Of the recent 52 rating actions, 6 were upgrades and 9 were downgrades. 12 analysts currently cover MED.
Analyst Recommendation Trends
MED analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$770M
↑ 101.6% YoY
Revenue Next Year
$602M
↓ 21.9% YoY
EPS This Year
$2.69
EPS Next Year
$1.78
↓ 33.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast MED EPS of $2.69 for the current fiscal year, based on estimates from 1 analysts. The MED revenue forecast is $770M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MED stock forecast is supported by two independent data sources: analyst consensus ratings from 12 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MED price target is $12.00 (-0.8% upside), with an analyst consensus of Hold.
The MED short-term stock prediction for tomorrow is $11.96 (-1.16%). The MED stock price prediction for 2027 estimates an average of $6. The MED stock prediction for 2030 projects a range of $3–$4.
Medifast, Inc. trades on NYSE under the ticker MED. The MED stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 33% of covering analysts.
Frequently asked questions
MED forecast · 8 questionsAccording to 12 Wall Street analysts, the average 12-month MED price target is $12.00, with a high forecast of $12.00 and a low of $12.00. The median price target is shown in the chart above when available. This implies -0.8% potential upside from the current price of $12.10.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.